Job Watch

Notice to Extend the Expiration Date of PA-16-443 "Drug Abuse Dissertation Research (R36)"

Notice NOT-DA-19-073 from the NIH Guide for Grants and Contracts

CLINICAL RESEARCH ASSISTANT - CHURPEK LAB - University of Wisconsin–Madison - Madison, WI

Indeed.com - Bioinformatics - Fri, 2019-10-04 14:57
Work experience should demonstrate dependability, flexibility, and maturity. The University of Wisconsin-Madison fulfills its public mission by creating a…
From University of Wisconsin–Madison - Fri, 04 Oct 2019 18:57:11 GMT - View all Madison, WI jobs
Categories: Job Watch

F. Hoffmann-La Roche AG: Semantic Data Integrator

New Scientist - Bioinformatics - Fri, 2019-10-04 13:42
F. Hoffmann-La Roche AG: Roche has been taken a strategic effort across functions and sites to improve data quality and to make data FAIR (findable, accessible, interop Switzerland (CH)
Categories: Job Watch

HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)

Funding Opportunity RFA-NS-20-011 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.

HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)

Funding Opportunity RFA-NS-20-010 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)

Funding Opportunity RFA-NS-20-008 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Technology Transfer (STTR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)

Funding Opportunity RFA-NS-20-009 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Technology Transfer (STTR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.

EMBL: Software Engineer - Reactome

New Scientist - Bioinformatics - Fri, 2019-10-04 05:38
Competitive Salary: EMBL: Software Engineer - Reactome Location: Cambridge, Cambridgeshire, England
Categories: Job Watch

NIH Operates Under a Continuing Resolution

Notice NOT-OD-20-003 from the NIH Guide for Grants and Contracts

Paramount Recruitment: Bioinformatics Data Manager- Brussels

New Scientist - Bioinformatics - Fri, 2019-10-04 03:47
Negotiable: Paramount Recruitment: Bioinformatics Data Manager- Brussels Biopharmaceutical, Drug Discovery, Data Management, Proteomics, CRISPR, Omics Data Our client, a global bioph Brussels, Belgium
Categories: Job Watch

Wellcome Sanger Institute: Postdoctoral Fellow - Functional Genomics

New Scientist - Bioinformatics - Thu, 2019-10-03 14:25
£31,897 to £39,240: Wellcome Sanger Institute: Postdoctoral Fellow - Functional Genomics Grade: PDF Salary per annum £31,897 to £39,240 Full Time or Part Time: Full Time Contra Hinxton, Cambridgeshire, England
Categories: Job Watch

Wellcome Sanger Institute: Senior Software Developer and Systems Administrator

New Scientist - Bioinformatics - Thu, 2019-10-03 14:25
up to £41,974: Wellcome Sanger Institute: Senior Software Developer and Systems Administrator Grade: 2 Salary per annum up to £41,974 Full Time or Part Time: Full Time Cont Hinxton, Cambridgeshire, England
Categories: Job Watch

AHRQ Notice of Extension of PA-17-077

Notice NOT-HS-19-022 from the NIH Guide for Grants and Contracts

Review of the Accuracy of Grants Information for Fiscal Year 2019

Notice NOT-OD-19-148 from the NIH Guide for Grants and Contracts

Pages

Subscribe to Anil Jegga aggregator - Job Watch